Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00642

Related search